I detail why it will likely beat the Nasdaq 100 in 2025.

Expand Energy (NASDAQ:EXE) +2.7% in Thursday's trading to an all-time high of $108.83 as J.P. Morgan launches coverage with an Outperform rating and $112 price target, citing large-scale exposure ...

Fintel reports that on January 16, 2025, JP Morgan initiated coverage of Expand Energy (NasdaqGS:EXE) with a Overweight recommendation. Price T Rowe Associates holds 14,203K shares representing 6. ...

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

OPKO Health will present at the J.P. Morgan Healthcare Conference and host investor meetings from January 13-16, 2025. OPKO Health, Inc. announced that its management will participate in the 43rd ...

I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth ...

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative ... will present at the 43rd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT on Thursday ...

Jan. 9, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference ... do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter ...

ProKidney's CEO will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference, which is a significant platform for biotech companies to showcase their advancements to potential ...